CTSA National Consortium

CTSI at UCSF is part of a national consortium that includes the 60 recipients of the Clinical and Translational Science Awards (CTSA) established by the National Institutes of Health (NIH). Including the nation’s leading biomedical institutions, the consortium works together with a common vision to improve health by transforming the clinical and translational research environment. The awards are administered by the National Center for Advancing Translational Sciences (NCATS), formerly known as the National Center for Research Resources (NCRR).

This partnership allows CTSI to amplify the best models of our work, and to take advantage of all that the national consortium has to offer.
Maninder "Mini" Kahlon, PhD; CTSI Deputy Director & CIO

Working under the banner of Accelerating Discoveries Toward Better Health, the activities of the national consortium are managed through a series of working groups. UCSF has representation on all national working groups and contributes to consortium-wide strategies focused on improving clinical and translational research. Highlights of CSTI's leadership and consortium activities include:

CTSA National Strategic Goals

Enhancing Consortium-Wide Collaborations: Research Networking group is led by CTSI Deputy Director and CIO Mini Kahlon, PhD.

Key Functional Area Committees

Child Health Oversight: Jennifer Puck, MD, serves as ex-officio for the national operations working group.

Informatics

Collaboration Facilitation: Led by Mini Kahlon, PhD, this group promotes efforts to enhance collaboration and learning by leveraging experts, communication, and virtual environments.

Human Studies Database: Led by Ida Sim, MD, PhD, this group is developing standard ontologies to describe human studies.

More About CTSAs

Through the NIH Roadmap for Medical Research and extensive community input, the CTSA program creates a definable academic home for clinical and translational research. CTSA institutions work to transform the local, regional, and national environment to increase the efficiency and quality of clinical and translational research nationwide.

The consortium has established five strategic goals to guide its activities:

  • Build National Clinical and Translational Research Capability
  • Provide Training and Improve the Career Development of Clinical and Translational Scientists
  • Enhance Consortium-Wide Collaborations
  • Improve the Health of our Communities and the Nation
  • Advance T1 Translational Research

More information on the CTSAs is available here.